The goal of this program is to improve the management of Hodgkin and non-Hodgkin lymphoma, acute myeloid leukemia (AML), and myeloproliferative neoplasms, myelodysplastic syndromes, and myelofibrosis. After hearing and assimilating this program, the clinician will be better able to: 1. Identify the second-line therapies included in the National Comprehensive Cancer Network guidelines for follicular lymphoma. 2. Recognize the role of autologous stem cell transplantation in patients with minimal residual disease-negative status in first complete remission after induction therapy for mantle cell lymphoma. 3. Improve treatment outcomes in patients with acute myeloid leukemia. 4. Analyze the efficacy of novel therapeutic approaches in acute myeloid leukemia, including venetoclax-based regimens and menin inhibitors. 5. Compare treatment strategies for myelodysplastic syndromes and myelofibrosis.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 903 Queens Lane
Pricing
CME included with membership · $1,095/yr
| Platinum Membership | $1,095/yr |
Collected from the provider’s public pages · source
Specialties served/covered
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Breast Imaging
- Cardiac Anesthesia
- Cardiovascular Disease
- Clinical Cardiac Electrophysiology
- Critical Care Medicine
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Facial Plastic & Reconstructive Surgery
- Gastroenterology
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Head & Neck Surgery
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Interventional Radiology
- Laryngology
- Medical Oncology
- Neonatal-Perinatal Medicine
- Nephrology
- Neuro Anesthesia
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neuroradiology
- Nuclear Medicine
- Obstetric Anesthesia
- Otology & Neurotology
- Pain Medicine
- Pediatric Anesthesia
- Pediatric Cardiology
- Pediatric Critical Care Medicine
- Pediatric Emergency Medicine
- Pediatric Gastroenterology
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Neurology
- Pediatric Otolaryngology
- Pediatric Radiology
- Pediatric Surgery
- Primary Care Sports Medicine
- Pulmonary Disease
- Regional Anesthesia & Acute Pain
- Rheumatology
- Rhinology
- Sleep Medicine
- Surgical Critical Care
- Surgical Oncology
- Thoracic Anesthesia
- Trauma Surgery
- Vascular Surgery
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Radiology
- Sports & Exercise Medicine
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Membership pricing — $1,095 / year
This provider prices CME through membership. Individual courses may also be sold separately.
See plans on audio-digest.orgListed by the provider
- Enduring / On-demand
- Credit · Up to 2 credits
- MOC · Up to 2 points
- Membership pricing
-
ReleasedSep 1, 2026
-
Last day to claim creditJun 19, 2028 2 years left
-
Opus Medicus, Inc. Myeloid Neoplasia: A Review of Clinical Features and Diagnostic Criteria. Part 1: The Myelodysplastic Syndromes
-
Physicians’ Education Resource Module 8: Myelodysplastic Syndromes (MDS)
-
National Comprehensive Cancer Network Emerging Treatment Strategies for High-Risk Myelodysplastic Syndromes
